PULSE BIOSCIENCES, INC. PE Ratio
The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
- PULSE BIOSCIENCES, INC. pe ratio for the quarter ending 2026-06-30 was -24.47, a change of -9.53 year-over-year.
- PULSE BIOSCIENCES, INC. pe ratio for the quarter ending 2026-03-31 was -19.72, a change of -1.75 year-over-year.
- PULSE BIOSCIENCES, INC. pe ratio for the quarter ending 2025-12-31 was -12.81, a change of 8.61 year-over-year.
- PULSE BIOSCIENCES, INC. pe ratio for the quarter ending 2025-09-30 was -16.03, a change of 7.35 year-over-year.
- PULSE BIOSCIENCES, INC. pe ratio for fiscal 2026 was -24.47.
- PULSE BIOSCIENCES, INC. pe ratio for fiscal 2025 was -12.81, a change of 8.61 from fiscal 2024.
- PULSE BIOSCIENCES, INC. pe ratio for fiscal 2024 was -21.42, a change of -5.43 from fiscal 2023.
- PULSE BIOSCIENCES, INC. pe ratio for fiscal 2023 was -15.99, a change of -14.23 from fiscal 2022.
- Available history
- 2016-06-30 to 2026-06-30
- Data captured
Historical PE Ratio
Annual PE Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |